Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab

Although several prognostic factors in nivolumab therapy have been reported in recurrent or metastatic head and neck cancer (RM-HNC) patients, these factors remain controversial. Here, we conducted a multicenter retrospective cohort study to investigate the impact of clinico-hematological factors on...

Descripción completa

Detalles Bibliográficos
Autores principales: Minohara, Kiyoshi, Matoba, Takuma, Kawakita, Daisuke, Takano, Gaku, Oguri, Keisuke, Murashima, Akihiro, Nakai, Kazuhiro, Iwaki, Sho, Hojo, Wataru, Matsumura, Ayano, Ozaki, Shinya, Ozawa, Taijiro, Harata, Ikuma, Tanaka, Nobukazu, Maseki, Shinichiro, Tsuge, Hiroshi, Imaizumi, Sae, Mitsuya, Shoji, Moribe, Kazuho, Esaki, Shinichi, Iwasaki, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379150/
https://www.ncbi.nlm.nih.gov/pubmed/34417539
http://dx.doi.org/10.1038/s41598-021-96538-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379150/
https://www.ncbi.nlm.nih.gov/pubmed/34417539
http://dx.doi.org/10.1038/s41598-021-96538-7

Ejemplares similares